- Home
- CERO vs XPON Comparison
CERO vs XPON Comparison
Compare CERO & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- XPON
- Stock Information
- Founded
- CERO 2017
- XPON 2016
- Country
- CERO United States
- XPON United States
- Employees
- CERO N/A
- XPON N/A
- Industry
- CERO
- XPON Electronic Components
- Sector
- CERO
- XPON Technology
- Exchange
- CERO Nasdaq
- XPON Nasdaq
- Market Cap
- CERO 3.5M
- XPON 3.0M
- IPO Year
- CERO N/A
- XPON 2022
- Fundamental
- Price
- CERO $7.50
- XPON $1.30
- Analyst Decision
- CERO Strong Buy
- XPON
- Analyst Count
- CERO 2
- XPON 0
- Target Price
- CERO $45.00
- XPON N/A
- AVG Volume (30 Days)
- CERO 95.7K
- XPON 3.0M
- Earning Date
- CERO 08-13-2025
- XPON 08-13-2025
- Dividend Yield
- CERO N/A
- XPON N/A
- EPS Growth
- CERO N/A
- XPON N/A
- EPS
- CERO N/A
- XPON N/A
- Revenue
- CERO N/A
- XPON $6,702,411.00
- Revenue This Year
- CERO N/A
- XPON $61.26
- Revenue Next Year
- CERO N/A
- XPON N/A
- P/E Ratio
- CERO N/A
- XPON N/A
- Revenue Growth
- CERO N/A
- XPON 23.07
- 52 Week Low
- CERO $6.71
- XPON $0.60
- 52 Week High
- CERO $895.40
- XPON $50.12
- Technical
- Relative Strength Index (RSI)
- CERO 40.75
- XPON 60.01
- Support Level
- CERO $7.27
- XPON $1.29
- Resistance Level
- CERO $8.83
- XPON $1.50
- Average True Range (ATR)
- CERO 0.43
- XPON 0.15
- MACD
- CERO -0.06
- XPON 0.04
- Stochastic Oscillator
- CERO 13.14
- XPON 47.78
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.